Clinical Trial Supply East Coast 2022
Sheraton King of Prussia, USA
19th-20th October, 2022
Clinical Trial Supply East Coast 2022
Advertisement
We are very happy to be at the Sheraton King of Prussia for our 20th Anniversary edition of Clinical Trial Supply East Coast on the 19th and 20th October 2022.
The conference covers all things CTS from reducing timelines and streamlining processes to handling clinical supplies in a decentralised trial world. Our expert panel will deliver case studies, thought leadership pieces, interactive panel and roundtable discussions.
Clinical Trial Supply East Coast offers opportunities for both learning and networking with peers from across the CTS sphere, via informal networking breaks and lunches, as well as a relaxed drinks reception at the end of Day 1.
Bringing together pharma and biotech experts to discuss new trends and opportunities
The Clinical Trial Supply East Coast is the meeting place for the pharmaceutical and biotechnology community to discover how to excel in clinical supply strategy as well as form key connections for long-term success.
It’s time to build relationships and take away valuable lessons to for clinical trial success moving forward so we look forward to seeing you there!
300+
Attendees
35+
Exhibitors
20+
Speakers
TESTIMONIAL
-
‘That was a superb day, it feels like we’ve been at a real, in person, conference!’ Worldwide Clinical Trials
-
‘A great event, I met more people than I do at an in-person event and I’ve got loads of follow ups’ Conversis
-
‘The whole setting is actually very well accomplished! Thanks again for the invitation!’ Apogenix AG

Matt Moyer
Director, Clinical Supply Technology,Merck
Biography: Matt is leading Merck adherence tracking technology and digital platform development and deployment efforts.
Session Details: View In Agenda

Stephanie Au
Associate Director,Merck

Frank Leu
CEO, Novapeutics,
Biography:
Frank Leu is a Co-Founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for type 2 diabetes. Prior, Frank was at a specialty pharma Verto Institute, developing biologic therapeutics for treating the neuroendocrine cancer. Frank graduated with a Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences in 2001, and then post-doc in a Howard Hughes Medical Institute laboratory at the Rockefeller University in molecular enzymology. He has served as an adjunct instructor at the Rutgers Cancer Institute of NJ, and is an adjunct professor at the pharmacology department of the Thomas Jefferson Medical University. Frank also founded BioPharMatrix developing blockchain solutions to lifescience innovations at all phases, and serves as advisor to the Pennovations center working with 1776 / Benjamins Desk. Frank is a thought leader in the blockchain architecture innovations in the life-sciences and drug development, Frank serves on multiple advisory boards and frequently served as chairman, speaker, moderator, and facilitator for many life-sciences and drug development events.
Session Details: View In Agenda

Nick Spring
CEO,FluoroMe

Luke Moyer
Director, Clinical Supply Chain Integration, Global IMSC,,Incyte
Biography: Luke has worked in Clinical Supply Chain Planning for nearly 20 years with Incyte, Janssen, Merck and Almac. He has experience in supply-planning, forecasting and simulation technologies, packaging/labeling design, distribution, cold chain, IRT, vendor selection and management, project management, comparator purchase, and CMC regulatory requirements. He has direct supply management experience for small molecule, biologics, devices, and stem cell medicines.
Session Details: View In Agenda

Lisa Kaufmann
Associate Director, Quality, Process and Risk Management,Astra Zeneca
Biography: Seasoned R&D Industry professional with over 30 years of experience in large pharma, mid-sized, start-up and virtual settings. Career appointments span the full spectrum of product life-cycle management, across every phase of development and every research platform, including pharmaceuticals, biologics, devices, combination products, gene and stem cell therapeutics, Phases I-IV. Achievements include contribution to the US and International market approval of 6 biopharmaceutical products.
Session Details: View In Agenda

Sherri Bourneuf
Project Quality Leader,Sanofi

Maria Napoliello Humagain
Senior Manager IRT Systems,Beigene
Biography: As a professional with an extensive background in IRT development and management, I am highly knowledgeable about the research industry for multiple functional areas. Based on the knowledge, I ensured the Clinical Trial Teams has an IRT leader for guiding them through the whole process and guarantee timely and high-quality services. In addition, I am a leading industry subject matter expert for IRT, vendor management, and building standards and procedures. Moreover, I employ this knowledge to keep the company updated with processes and industry standards implement SOPs quickly to fulfill regulatory expectations.
Session Details: View In Agenda

Janique Sam-Pan
Associate Director Clinical Supplies,Esperion
Biography: Pharmaceutical and Biotechnology professional with over fifteen years of experience in manufacturing, packaging, labeling, and clinical supply chain management. Special expertise in forecasting, planning and budgeting of clinical supply chain. Supplied and managed clinical materials from preclinical through Phase III. Extensive abilities in project management and process improvement. Highly trained in GXPs and ICH guidelines, FDA, and EMA regulations.
Session Details: View In Agenda

Dawn Wright
Global Clinical Supply Planning,Incyte
Biography: Accomplished leader experienced in clinical trials and CROs looking for an opportunity to grow into a new area by building on knowledge and skills acquired over many years in the industry. Proven track record for managing global teams across multiple sites in the US and UK. Extensive background in planning of clinical study activities and leading matrix teams. Experienced in leading after action reviews and implementing process improvements that address the root cause and improve processes.
Session Details: View In Agenda

Jennifer L. Northcott
Associate Director, Global Clinical Supply Chain,Merck
Biography: An agile CPM certified project manager currently working within the clinical supply chain managing a team of project managers eager to optimize and strength the the supply chain and get medicine to patients more efficiently. Prior 13 years of pharmaceutical experience, 5 years' managing clinical trials and 8 years’ experience executing high level scientific engagement meetings for various therapeutic areas, orchestrating cross-functional presence at international and national congresses, and managing clinical and pre-clinical investigator initiated trials.
Session Details: View In Agenda

Sean Smith
Biological Threat Exclusion Coordinator,US Customs and Border Protection
Biography: Sean Smith is a Biological Threat Exclusion Coordinator (BTEC) for CBP in the Office of Field Operations/ Agriculture Programs and Trade Liaison/ Agro/Bio-Terrorism Countermeasures. As a BTEC, Mr. Smith is charged with supporting and developing U.S. Customs and Border Protection (CBP) operational capacity and capability in preventing tools of agro/bio-terrorism from entering the U.S. Mr. Smith joined CBP in 2005 as an Agriculture Specialist (CBPAS) and was promoted to Supervisory CBPAS in 2008. He has served CBP in the following ports of entry: San Diego, San Ysidro, Otay Mesa and Boston Logan Airport. From 2011- 2018, Mr. Smith served as the primary Public Affairs Liaison and Border Community Liaison, respectively, for CBP in New England. He has also volunteered to assist in past domestic and international CBP disaster recovery operations, including: Hurricane Ike (2008), 'Operation Safe Return' (Haitian Relief Effort- 2010), and Hurricane Harvey, DHS Surge Capacity Force (2017). Prior to CBP, Mr. Smith contributed to wildlife conservation for nearly a decade, completing field work on rare endemic Hawaiian birds on the Big Island of Hawaii, and raising rare and endangered birds (in some cases, extinct in the wild) at the San Diego Zoo's Avian Propagation Center. Also, Mr. Smith is a former reserve firefighter and EMT for the City of Borrego Springs in California. He holds a Bachelor of Science degree in Ecology and Systematic Biology from Cal Poly San Luis Obispo, California. Mr. Smith, his wife, two children, one dog, and one chicken live in an old farmhouse in Massachusetts.
Session Details: View In Agenda

Adam Pitt
Biological Threat Exclusion Coordinator,US Customs and Border Protection

Haneen Mazahreh-Boivert
Sr. Director, Global Clinical Supply,Optinose

Amanda Murphy
Director of Product Management,GlobalData
Biography: Amanda Murphy is the Director of Product Management at GlobalData, a company that focuses on research, data analytics and consulting that provide actionable insight into the pharmaceutical and medical device sectors. She has 10+ years of experience working in pharmaceutical data science and web platform development (including BioPharm Insight, Lead Sheet, and the Pharma Intelligence Center). She has developed models and solutions to support Clinical Operations & Feasibility teams plan and optimize trials, including an e-feasibility questionnaire tool resulting in 4x faster response rates from sites. Amanda also has many years of experience supporting business development at CROs through data-driven lead delivery and CRM integration solutions.
Session Details: View In Agenda

Derrick L Kearney
Supervisory Import Specialist, Pharmaceuticals, Health and Chemicals Center,US Customs and Border Protection
Biography: Derrick L. Kearney – Supervisory Import Specialist - Pharmaceuticals, Health and Chemicals Center of Excellence and Expertise, Partnership Division, U.S. Customs and Border Protection (CBP). Mr. Kearney joined CBP in 2007, and is currently assigned to the Port of Philadelphia, PA. Previous positions within CBP include Import Specialist and Trade Operations Program Manager at the Port of JFK, New York. Prior to joining CBP, Mr. Kearney worked for the New York City Office of the Comptroller. Mr. Kearney is an Air Force veteran. Educational accomplishments include numerous classes, seminars and workshops as a member of CBP, and a Master’s of Public Administration (MPA) Degree from Baruch College, City University of New York.
Session Details: View In Agenda

Damian Procak
Operations Director,Inceptua Clinical Trial Supply




































The medical device and diagnostic industry is currently valued at over $350 billion. Technological advances in medical device and diagnostics design are driven by an increasingly demanding market and legislative requirements. A growing patient population and a worldwide governmental drive towards preventive therapies are also fuelling the development of innovative devices.
Medical Device Developments is published in response to the increasing information needs of the major global medical device manufacturers/OEMs. The publication, which is published biannually, will incorporate authoritative reviews of current trends and emerging technologies, and provide the industry's decision-makers with clear, concise and unbiased technical articles and case histories on cutting edge developments, products and applications, drawing on the expertise of leading engineers and designers from around the globe.
L: www.linkedin.com/groups/2098440
T: Medical Device (@MedDeviceDevpt) / Twitter


Today’s healthcare providers are faced with the almost impossible task of increasing the standard of care afforded to each patient, while reducing the operational costs associated with providing this improved level of care. The care delivered throughout a healthcare facility is crucial to patient outcomes; from the emergency department through to outpatient operations, encompassing wound care, critical care and clinical care at the bedside..
e-Care, which spans the entire spectrum of patient care, is also a rapidly growing area, and one that healthcare professionals are embracing not only to improve the standard of care in areas including medication administration and patient education, but also to reduce spending. Throughout a patient’s stay in a medical facility, clinicians are faced with inevitable challenges including staff management and education, infection control and equipment failure.
Practical Patient Care is published specifically to provide medical practitioners and senior managers with the information they need in order to deliver successful care management strategies that will allow them to achieve their objective of improving patient care at a reduced cost..
L: www.linkedin.com/company/practical-patient-care
T: twitter.com/P_PatientCare

Practical Patient Care
Sponsorship Opportunities
Are you a solution provider to the clinical supply industry? Do you want to meet with leading industry leaders under one roof? If so, to enquire about sponsorship opportunities for the conference, please contact:
Paul Adams
Sponsorship Sales Director – Healthcare
E-mail: pauladams@arena-international.com
Conference Enquiries
The Clinical Trial Supply East Coast programme is written in collaboration with industry, if you would have a case study, idea or just a comment, please contact:
Douglas Webber
Conference Producer